Viking Therapeutics Inc (VKTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Viking Therapeutics Inc’s stock clocked out at $51.01, down -0.51% from its previous closing price of $51.27. In other words, the price has decreased by -$0.51 from its previous closing price. On the day, 1.77 million shares were traded. VKTX stock price reached its highest trading level at $53.1699 during the session, while it also had its lowest trading level at $50.1711.

Ratios:

To gain a deeper understanding of VKTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.48 and its Current Ratio is at 29.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on June 27, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.

On May 16, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $115 to $116.

Oppenheimer reiterated its Outperform rating for the stock on March 26, 2024, while the target price for the stock was revised from $116 to $138.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 03 ’24 when ZANTE GREG sold 66,756 shares for $74.69 per share. The transaction valued at 4,986,008 led to the insider holds 174,854 shares of the business.

Mancini Marianna sold 281,425 shares of VKTX for $22,136,474 on May 01 ’24. The Chief Operating Officer now owns 348,508 shares after completing the transaction at $78.66 per share. On Feb 09 ’24, another insider, Lian Brian, who serves as the President & CEO of the company, sold 45,000 shares for $29.90 each. As a result, the insider received 1,345,500 and left with 2,139,882 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 5624770560 and an Enterprise Value of 4662986240.

Stock Price History:

The Beta on a monthly basis for VKTX is 1.02, which has changed by 2.188125 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is -18.64%, while the 200-Day Moving Average is calculated to be 27.74%.

Shares Statistics:

It appears that VKTX traded 3.39M shares on average per day over the past three months and 4375180 shares per day over the past ten days. A total of 110.27M shares are outstanding, with a floating share count of 102.50M. Insiders hold about 7.05% of the company’s shares, while institutions hold 72.85% stake in the company. Shares short for VKTX as of 1718323200 were 12670098 with a Short Ratio of 3.74, compared to 1715731200 on 12174916. Therefore, it implies a Short% of Shares Outstanding of 12670098 and a Short% of Float of 15.49.

Most Popular